CXXC5 and obesity disorder: As for the HFD‐fed Cxxc5−/− mice, HFD‐fed Cxxc5+/+ mice administered KY19334 revealed a reduction in abnormal metabolic phenotypes, such as obesity, insulin resistance and other diabetes‐related phenotypes.